Incyte Corporation (INCY)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 77.36 |
| Open | 77.32 |
| Bid | 72.85 x 1400 |
| Ask | 76.32 x 1400 |
| Day's range | 75.03 - 77.63 |
| 52-week range | 61.91 - 85.97 |
| Volume | |
| Avg. volume | 1,451,203 |
| Market cap | 16.752B |
| Beta (5Y monthly) | 0.71 |
| PE ratio (TTM) | 18.02 |
| EPS (TTM) | 4.20 |
| Earnings date | 01 Aug 2022 - 05 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 91.86 |
- Motley Fool
3 Cheap Growth Stocks Near Their 52-Week Lows to Buy and Forget
Sometimes, the smart-money move is to dive in on a dip and leave your stocks alone for a decade or more.
- Zacks
MorphoSys (MOR) Gains on Oncology Collaboration With Pfizer
MorphoSys (MOR) and Pfizer collaborate to develop a combination of MOR's Monjuvi and Pfizer's checkpoint inhibitor candidate, TTI-622, for treating r/r DLBCL.
- Zacks
Lilly (LLY), Incyte's Olumiant Gets FDA Nod for Alopecia Areata
Lilly (LLY) and Incyte's Olumiant is the first-ever FDA-approved systemic treatment for alopecia areata patients.
© 2022 Yahoo. All rights reserved.
